Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme (Q44383427)
Jump to navigation
Jump to search
scientific article published on 30 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme |
scientific article published on 30 October 2011 |
Statements
1 reference
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme (English)
1 reference
B Zinman
1 reference
W E Schmidt
1 reference
A Moses
1 reference
N Lund
1 reference
S Gough
1 reference
30 October 2011
1 reference
1 reference
14
1 reference
1
1 reference
77-82
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference